Secernin 1 Antikörper (C-Term)
-
- Target Alle Secernin 1 (SCRN1) Antikörper anzeigen
- Secernin 1 (SCRN1)
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Secernin 1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA)
- Kreuzreaktivität (Details)
- Species reactivity (tested):Human, mouse, rat
- Immunogen
- 20 amino acid peptide near the carboxy terminus of human SCRN1
- Top Product
- Discover our top product SCRN1 Primärantikörper
-
anti-Secernin 1 (SCRN1) (AA 10-37), (N-Term) antibody
SCRN1 Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB26453 unconjugated
anti-Secernin 1 (SCRN1) (AA 2-414) antibodySCRN1 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Secernin 1 (SCRN1) (AA 2-414) antibodySCRN1 Reaktivität: Human WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Secernin 1 (SCRN1) antibodySCRN1 Reaktivität: Maus, Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Secernin 1 (SCRN1) (C-Term) antibodySCRN1 Reaktivität: Human, Maus, Ratte WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1.0 mg/mL
- Buffer
- PBS containing 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store the antibody (in aliquots) at -20 °C.
-
- Target
- Secernin 1 (SCRN1)
- Andere Bezeichnung
- Secernin-1 (SCRN1) (SCRN1 Produkte)
- Hintergrund
- SCRN1 was first identified as a cytosolic protein that is involved in the regulation of exocytosis from peritoneal mast cells. More recent studies have shown that SCRN1 expression is upregulated in gastric cancer cell lines and may possess epitopes that could function as tumor-associated antigens, potentially providing targets for cancer vaccines in the treatment of gastric cancers. Another report indicates that decreased expression of SCRN1 via RNAi expression resulted in significantly lower rates of cell growth in colorectal cancer cell lines, and increased SCRN1 expression in patients with colorectal cancer correlated with poor prognosis, suggesting that SCRN1 may also be involved in the regulation of cell growth and might be useful as a prognostic tool.Synonyms: KIAA0193
- Gen-ID
- 9805
- NCBI Accession
- NP_001138985
- UniProt
- Q12765
-
